We are an investment management firm that captures the opportunity arising from the profound transformation of the global healthcare industry.

what we do

EntryPoint's strategies will be driven by scientific, systematic and quantitative techniques to investing in the global healthcare industry. We provide institutional and family office investors with a range of uniquely designed, differentiated, high-capacity public equity portfolios tailored to investors' appetite for risk, volatility and return.

The companies at the forefront of this transformation are poised to benefit from superior organic growth prospects in large, growing domestic and international markets, and provide investors with the potential for superior returns relative to traditional healthcare industry benchmarks. We plan to target the critical innovation themes with the greatest potential to impact the industry and propel this transformation.

White Paper

White Paper Preview

MEASURING HEALTH IMPACT:

Quantifying the True Value of Health Enterprises

download now

who we are

Daniel Lubin Headshot
Daniel C. Lubin Founder & CEO
Daniel Lubin is the founder and CEO of

EntryPoint Capital

. Daniel also serves as a Managing Partner and co-founder of Radius Ventures LLC, a New York-based venture capital organization that invests in leading-edge, late-stage venture health and life sciences companies. In his role at Radius, Daniel focused on the firm's investment effort in the healthcare services/IT sector, serving on numerous public and private boards, including Tabula Rasa Healthcare (NASDAQ: TRHC), Invicro, Aethon, Healthsense and Syft. Daniel is also Chairman of Upsher Management Company, a single family office built upon his family's 85-year legacy as operators, clinicians and investors in the healthcare industry.
Read More